11/13/2026 | Press release | Archived content
Oncology technology and data leader Ontada recently announced a strategic collaboration with the healthcare company Commure, in which it will help to bring Commure's clinical AI platform into iKnowMed - Ontada's precision point-of-care technology designed to help enhance patient care and reduce administrative burden for oncologists. Through this partnership, Commure's advanced AI platform will pair with the oncology expertise of Ontada, together "delivering ambient documentation, chart and visit summaries, smart coding, an AI Practice Assistant, and dictation inside the iKnowMed environment clinicians already use."
Ontada's Chief Product Officer Rob Helton explained the importance of this announcement in the company's press release, stating "We believe AI can deliver greater value when it is connected to the technology and workflows oncology practices already use, rather than operating as another standalone solution. By unifying these capabilities into iKnowMed workflows clinicians use every day, practices can immediately benefit while creating the foundation for a much broader Intelligent Medical Record, one that helps clinicians work more efficiently, helps practices operate more effectively and continually becomes smarter as new capabilities are added."
Augmedix, a subsidiary of Commure, was founded in 2012 by Ian Shakil and Pelu Tan, and quickly rose to prominence as a key player in the digital health industry, before being acquired by Commure in 2024. Since this acquisition, the Augmedix technologies have been integrated into the Commure platform, and now with the help of Ontada, into the iKnowMed system - bundling together a robust suite of healthcare technologies with the sole purpose of taking hematology and oncology care to the next level. For more information on this story, view the Ontada press release below.
See related materials: